References:
1. Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD,
Danielson GK. Ebstein’s anomaly. Circulation. 2007 Jan
16;115(2):277-85.
2. Luu Q, Choudhary P, Jackson D, Canniffe C, McGuire M, Chard
R, Celermajer DS. Ebstein’s anomaly in those surviving to adult life–a
single centre experience. Heart, Lung and Circulation. 2015 Oct
1;24(10):996-1001.
3. Hebe J. Ebstein’s anomaly in adults. Arrhythmias: diagnosis
and therapeutic approach. The Thoracic and cardiovascular surgeon.
2000;48(04):214-9.
4. Katritsis DG, Wellens HJ, Josephson ME. Mahaim accessory pathways.
Arrhythmia & electrophysiology review. 2017 Apr;6(1):29.
5. Ueshima K, Nakamura Y, Takeno S, Miyake T, Takemura T.
Atriofascicular Mahaim with Ebstein anomaly: A case report. Journal of
arrhythmia. 2017 Oct;33(5):508-10.
6. Oka K, Seki M, Kataoka K, Sato T, Imai Y, Yamagata T. Percutaneous
Atrial Septal Defect Closure in Adult Ebstein’s Anomaly with Exertional
Hypoxemia. International Heart Journal. 2020:19-641.
7. Yuan SM. Ebstein’s Anomaly: Genetics, Clinical Manifestations, and
Management. PediatrNeonatol. 2017 Jun;58(3):211-215. doi:
10.1016/j.pedneo.2016.08.004. Epub 2016 Nov 19.PMID: 28017577
8. Green CE, Gottdiener JS, Goldstein HA. Atrial septal defect. Semin
Roentgenol. 1985
Jul;20(3):214-25. doi: 10.1016/0037-198x(85)90005-7. PMID: 3898390.
9. Moake L, Ramaciotti C. Atrial septal defect treatment options. AACN
Clin Issues. 2005 AprJun;16(2):252-66. doi:
10.1097/00044067-200504000-00015. PMID: 15876892.
10. Numan MT, Ali SK. Trans-catheter closure of large secondum atrial
septal defects in patients with Ebstein’s malformation of the tricuspid
valve: A report of two cases. Heart Views. 2007 Jan 1;8(3):109.
11. Pradhan P, Jain S, Sen S, Dalvi B. Use of cribriform amplatzer
septal occluder in the pediatric population: Feasibility, safety, and
technical considerations. Annals of Pediatric Cardiology. 2021
Apr;14(2):159.
12. Tal R, Dahud Q, Lorber A. Fenestrated atrial septal defect
percutaneously occluded by a single device: procedural and financial
considerations. Cardiology and therapy. 2013 Jun;2(1):97-102.